Ionis partners up with Metagenomi on drug discovery pact, shelling out $80M upfront

Ionis is no stranger to large deals and working with other entities, but its latest deal will see the company work Metagenomi to go after the liver.

The pair will conduct research to deliver up to four genetic targets, with Ionis having the right to add four additional targets once...

Click to view original post